semaglutide methylcobalamin 2.5 mg 0.5 Compounded Weight Management Program Semaglutide Micro-Dose 3-Month Plan |
Description
Your health and safety are priorities
Sterne J
Eligibility for our compounded GLP-1 program is based on BMI and clinical criteria reviewed by a licensed provider
The STEP 1 trial with 1,961 participants [1] documented that 74% of patients experienced at least one gastrointestinal side effect, with nausea affecting 44% and diarrhea occurring in 30%
Response variability is why genetic testing becomes valuable: PlexusDx's Precision Peptide Genetic Test examines variants in GLP1R, GIPR, FTO, and MC4R genes to predict how your unique metabolic pathways may respond to each compound
